Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion

European Journal of Immunology

Volumn 44, Issue 10, 2014, Pages 2979-2989

  Herrath, Jessica ^a   Chemin, Karine ^a   Albrecht, Inka ^a   Catrina, Anca I ^a   Malmström, Vivianne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD39; FOXP3; Regulatory T cells; Rheumatoid arthritis; Th17

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; CD39 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; APYRASE; IL17A PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; CELL SEPARATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); SYNOVIAL FLUID; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APYRASE; ARTHRITIS, RHEUMATOID; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; SYNOVIAL FLUID; T-LYMPHOCYTE SUBSETS;

EID: 84912116152     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344140     Document Type: Article

References (39)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
2. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
3. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. and Yamaguchi, T., Regulatory T cells: how do they suppress immune responses? Int. Immunol. 2009. 21: 1105-1111.
4. Costantino, C. M., Baecher-Allan, C. M. and Hafler, D. A., Human regulatory T cells and autoimmunity. Eur. J. Immunol. 2008. 38: 921-924.
5. Klareskog, L., Ronnelid, J. and Holm, G., Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition. J. Intern. Med. 1995. 238: 191-206.
6. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 2003. 33: 215-223.
7. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 2004. 6: R335-R346.
8. van Amelsfort, J. M., Jacobs, K. M., Bijlsma, J. W., Lafeber, F. P. and Taams, L. S., CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004. 50: 2775-2785.
9. Maliszewski, C. R., Delespesse, G. J., Schoenborn, M. A., Armitage, R. J., Fanslow, W. C., Nakajima, T., Baker, E. et al., The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 1994. 153: 3574-3583.
10. Koziak, K., Sevigny, J., Robson, S. C., Siegel, J. B. and Kaczmarek, E., Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb. Haemost. 1999. 82: 1538-1544.
11. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
12. Kaczmarek, E., Koziak, K., Sevigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H. et al., Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 1996. 271: 33116-33122.
13. Dwyer, K. M., Deaglio, S., Gao, W., Friedman, D., Strom, T. B. and Robson, S. C., CD39 and control of cellular immune responses. Purinergic Signal. 2007. 3: 171-180.
14. Huang, S., Apasov, S., Koshiba, M. and Sitkovsky, M., Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997. 90: 1600-1610.
15. + regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol. 2009. 183: 7602-7610.
16. Moncrieffe, H., Nistala, K., Kamhieh, Y., Evans, J., Eddaoudi, A., Eaton, S. and Wedderburn, L. R., High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 2010. 185: 134-143.
17. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007. 110: 1225-1232.
18. Herrath, J., Muller, M., Amoudruz, P., Janson, P., Michaelsson, J., Larsson, P. T., Trollmo, C. et al., The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur. J. Immunol. 2011. 41: 2279-2290.
19. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 2004. 172: 6435-6443.
20. + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 2007. 147: 412-418.
21. high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm. Bowel Dis. 2006. 12: 447-456.
22. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T. et al., Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007. 13: 423-431.
23. Perry, C., Hazan-Halevy, I., Kay, S., Cipok, M., Grisaru, D., Deutsch, V., Polliack, A. et al., Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia. Ann. Hematol. 2012. 91: 1271-1279.
24. Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E. et al., Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin. Cancer Res. 2009. 15: 6348-6357.
25. Kas-Deelen, A. M., Bakker, W. W., Olinga, P., Visser, J., de Maar, E. F., van Son, W. J., The, T. H. et al., Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells. FEBS Lett. 2001. 491: 21-25.
26. Leal, D. B., Streher, C. A., de M. Bertoncheli, C., Carli, L. F., Leal, C. A., da Silva, J. E., Morsch, V. M. et al., HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim. Biophys. Acta 2005. 1746: 129-134.
27. Regateiro, F. S., Cobbold, S. P. and Waldmann, H., CD73 and adenosine generation in the creation of regulatory microenvironments. Clin. Exp. Immunol. 2013. 171: 1-7.
28. Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C. et al., Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 2003. 198: 783-796.
29. Nakamachi, Y., Koshiba, M., Nakazawa, T., Hatachi, S., Saura, R., Kurosaka, M., Kusaka, H. et al., Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis Rheum. 2003. 48: 668-674.
30. + T cells denotes both regulatory and memory populations. Am. J. Transplant. 2009. 9: 2303-2311.
31. + T cells denotes a regulatory memory phenotype. Am. J. Transplant. 2010. 10: 2410-2420.
32. Melton, A. C., Melrose, J., Alajoki, L., Privat, S., Cho, H., Brown, N., Plavec, A. M. et al., Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation. PLoS One 2013. 8: e58966.
33. Adamik, J., Henkel, M., Ray, A., Auron, P. E., Duerr, R. and Barrie, A., The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells. Cytokine 2013. 64: 404-412.
34. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M. and Shevach, E. M., Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008. 181: 1908-1916.
35. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de, Roo, C. J., Joosten, L. A. and van den Berg, W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004. 50: 650-659.
36. Lister, M. F., Sharkey, J., Sawatzky, D. A., Hodgkiss, J. P., Davidson, D. J., Rossi, A. G. and Finlayson, K., The role of the purinergic P2×7 receptor in inflammation. J. Inflamm. (Lond.) 2007. 4: 5.
37. Patel, D. D., Lee, D. M., Kolbinger, F. and Antoni, C., Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann. Rheum. Dis. 2013. 72(Suppl 2): ii116-ii123.
38. Burgess, A., Vigneron, S., Brioudes, E., Labbe, J. C., Lorca, T. and Castro, A., Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. USA 2010. 107: 12564-12569.
39. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J., Thiel, A. et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007. 37: 2378-2389.